Page 26 - TD-2-2

Tumor Discovery Practice and consideration of master protocol design

Res, 27(5): 1513–1530. Oncol, 20(6): e336–e342.
63. Dunnett CW, 1955, A multiple comparison procedure for 66. World Medical Association, 2013, World Medical
comparing several treatments with a control. J Am Stat Association Declaration of Helsinki: Ethical principles
Assoc, 50(272): 1096–1121. for medical research involving human subjects. JAMA,
310(20): 2191–2194.
64. Kesselmeier M, Benda N, Scherag A, 2020, Effect size
estimates from umbrella designs: Handling patients with a 67. Park JJH, Ford N, Xavier D, et al., 2021, Randomised
positive test result for multiple biomarkers using random or trials at the level of the individual. Lancet Glob Health,
pragmatic subtrial allocation. PLoS One, 15(8): e0237441. 9(5): e691–e700.
65. Sudhop T, Brun NC, Riedel C, et al., 2019, Master protocols 68. Redman MW, Allegra CJ, 2015, The master protocol concept.
in clinical trials: A universal Swiss Army knife? Lancet Semin Oncol, 42(5): 724–730.

Volume 2 Issue 2 (2023) 20 https://doi.org/10.36922/td.342